Back
4D Molecular Therapeutics Stock Price Chart
Sponsored
FDMT
Sponsored
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Buy
55
FDMT
4D Molecular Therapeutics
Last Price:
26.24
Seasonality Move:
-18.33%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).- The current trend is relatively stagnant and FDMT is experiencing slight buying pressure.
4D Molecular Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.38 | Buy |
20-day SMA: | 25.57 | Buy |
50-day SMA: | 28.29 | Sell |
200-day SMA: | 19.44 | Buy |
8-day EMA: | 25.9 | Buy |
20-day EMA: | 26.12 | Buy |
50-day EMA: | 26.52 | Buy |
200-day EMA: | 21.8 | Buy |
4D Molecular Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 51.86 | Buy |
Chaikin Money Flow: | 70295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.56 - 27.56) | Buy |
Bollinger Bands (100): | (19.92 - 30.06) | Buy |
4D Molecular Therapeutics Technical Analysis
Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for 4D Molecular Therapeutics Stock
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 26.79 while FDMT 8-day simple moving average is 25.38, which is a Buy signal.
- The stock price of FDMT is 26.79 while 4D Molecular Therapeutics 20-day SMA is 25.57, which makes it a Buy.
- 4D Molecular Therapeutics 50-day simple moving average is 28.29 while FDMT share price is 26.79, making it a Sell technically.
- FDMT stock price is 26.79 and 4D Molecular Therapeutics 200-day simple moving average is 19.44, creating a Buy signal.
FDMT Technical Analysis vs Fundamental Analysis
Buy
55
4D Molecular Therapeutics (FDMT)
is a Buy
Is 4D Molecular Therapeutics a Buy or a Sell?
-
4D Molecular Therapeutics stock is rated a Buy
The current 4D Molecular Therapeutics [FDMT] share price is $26.79. The Score for FDMT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
4D Molecular Therapeutics Stock Info
Market Cap:
1.33B
Price in USD:
26.79
Share Volume:
253.68K
4D Molecular Therapeutics 52-Week Range
52-Week High:
36.25
52-Week Low:
9.44
Buy
55
4D Molecular Therapeutics (FDMT)
is a Buy
4D Molecular Therapeutics Share Price Forecast
-
What is the 4D Molecular Therapeutics stock price today?
The 4D Molecular Therapeutics stock price is 26.79 USD today. -
Will FDMT stock go up or go down?
4D Molecular Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is 4D Molecular Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, 4D Molecular Therapeutics is not overvalued.
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 26.79 while FDMT 8-day exponential moving average is 25.90, which is a Buy signal.
- The stock price of FDMT is 26.79 while 4D Molecular Therapeutics 20-day EMA is 26.12, which makes it a Buy.
- 4D Molecular Therapeutics 50-day exponential moving average is 26.52 while FDMT share price is 26.79, making it a Buy technically.
- FDMT stock price is 26.79 and 4D Molecular Therapeutics 200-day simple moving average is 21.80, creating a Buy signal.
Fundamental Analysis of 4D Molecular Therapeutics
Is 4D Molecular Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
Technical Analysis of 4D Molecular Therapeutics
Should I short 4D Molecular Therapeutics stock?
- FDMT Moving Average Covergence Divergence (MACD) indicator is -0.59, suggesting 4D Molecular Therapeutics is a Sell
- 4D Molecular Therapeutics Relative Strength Index (RSI) is 51.86, which suggest 4D Molecular Therapeutics is overbought
- The Bollinger Bands (25) for 4D Molecular Therapeutics is (24.56 - 27.56), which suggest 4D Molecular Therapeutics is a Buy
- The Bollinger Bands (100) for 4D Molecular Therapeutics is (19.92 - 30.06), which suggest 4D Molecular Therapeutics is a Buy
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.